KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Net Margin (2016 - 2025)

AbbVie (ABBV) has disclosed Net Margin for 14 consecutive years, with 10.92% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1107.0% to 10.92% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6.92% through Dec 2025, down 69.0% year-over-year, with the annual reading at 6.92% for FY2025, 69.0% down from the prior year.
  • Net Margin for Q4 2025 was 10.92% at AbbVie, up from 1.19% in the prior quarter.
  • The five-year high for Net Margin was 33.19% in Q1 2022, with the low at 0.79% in Q1 2023.
  • Average Net Margin over 5 years is 12.8%, with a median of 10.87% recorded in 2024.
  • The sharpest move saw Net Margin skyrocketed 2705bps in 2021, then tumbled -3398bps in 2023.
  • Over 5 years, Net Margin stood at 27.17% in 2021, then tumbled by -40bps to 16.35% in 2022, then tumbled by -65bps to 5.76% in 2023, then crashed by -103bps to 0.15% in 2024, then soared by 7271bps to 10.92% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 10.92%, 1.19%, and 6.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.